Document is current
Any future updates will be listed below
-
Authors
Sugimoto, Keishiro
Takahashi, Kuniaki https://orcid.org/0000-0001-5748-7700
Okune, Mana
Ueno, Masafumi
Fujita, Tsutomu
Doi, Hirosato
Tobaru, Tetsuya
Takanashi, Shuichiro
Kinoshita, Yoshihisa
Okawa, Yasuhide
Fuku, Yasushi
Komiya, Tatsuhiko
Tsujita, Kenichi
Fukui, Toshihiro
Shimokawa, Tomoki
Watanabe, Yusuke
Kozuma, Ken
Sakaguchi, Genichi
Nakazawa, Gaku
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02894255 at ClinicalTrials.govDocuments that mention this clinical trial
Impact of quantitative flow ratio on graft function in patients undergoing coronary artery bypass grafting
https://doi.org/10.1007/s12928-023-00929-8
- License Information
-
More Information
Article History
Received: 26 December 2022
Accepted: 17 March 2023
First Online: 5 April 2023
Declarations
:
: Dr. Tsujita reports research grants for the university from PPD-Shin Nippon Biomedical Laboratories, Alexion Pharmaceuticals, Abbott Medical, Bayer Yakuhin, Boehringer Ingelheim, Daiichi Sankyo, ITI, Ono Pharmaceutical, Otsuka Pharmaceutical, and Takeda Pharmaceutical and personal consultancy fees from Abbott Medical, Amgen, AstraZeneca, Bayer Yakuhin, Daiichi Sankyo, Medtoronic, Kowa Pharmaceutical, Novartis Pharma, Otsuka Pharmaceutical, Pfizer Japan, and Janssen Pharmaceutical, outside the submitted work. All other authors declare no competing interests.
